Author:
Guo Shizheng,Yang Liming,Zhu Xueyan,Zhang Xiaoxuan,Sun Zhanshan,Meng Lingfei,Wang Yangwei,Li Jian,Cheng Siyu,Zhuang Xiaohua,Cui Wenpeng
Abstract
Abstract
Background
The first six months of therapy represents a high-risk period for peritoneal dialysis (PD) failure. The risk of death in the first six months is higher for older patients treated with urgent-start PD (USPD). However, there are still gaps in research on mortality and risk factors for death in this particular group of patients. We aimed to investigate mortality rates and risk factors for death in older patients with end-stage renal disease (ESRD) receiving USPD within and after six months of therapy.
Methods
We retrospectively studied the clinical information of older adults aged ≥ 65 years with ESRD who received USPD between 2013 and 2019 in five Chinese hospitals. Patients were followed up to June 30, 2020. The mortality and risk factors for death in the first six months of USPD treatment and beyond were analyzed.
Results
Of the 379 elderly patients in the study, 130 died over the study period. During the follow-up period, the highest number (45, 34.6%) of deaths occurred within the first six months. Cardiovascular disease was the most common cause of death. The baseline New York Heart Association (NYHA) class III–IV cardiac function [hazard ratio (HR) = 2.457, 95% confidence interval (CI): 1.200–5.030, p = 0.014] and higher white blood cell (WBC) count (HR = 1.082, 95% CI: 1.021–1.147, p = 0.008) increased the mortality risk within six months of USPD. The baseline NYHA class III–IV cardiac function (HR = 1.945, 95% CI: 1.149–3.294, p = 0.013), lower WBC count (HR = 0.917, 95% CI: 0.845–0.996, p = 0.040), lower potassium levels (HR = 0.584, 95% CI: 0.429–0.796, p = 0.001), and higher calcium levels (HR = 2.160, 95% CI: 1.025–4.554, p = 0.043) increased the mortality risk after six months of USPD.
Conclusion
Different risk factors correlated with mortality in older adults with ESRD within and after six months of undergoing USPD, including baseline NYHA class III–IV cardiac function, WBC count, potassium, and calcium levels.
Funder
the Health and Technology Innovation Development Program of Jilin Province
the Science and Technology department of Jilin Province
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.
2. Yin Y, Cao Y, Yuan L. Outcome and safety of unplanned-start peritoneal Dialysis according to Break-In periods: a systematic review and Meta-analysis. Blood Purif. 2020;50(2):1–13.
3. Wańkowicz Z. Peritoneal dialysis and its role in the demography and epidemiology of chronic kidney disease. Pol Arch Med Wewn. 2009;119(12):810–4.
4. PONCE D, BRABO MA, BALBI AL. Urgent start peritoneal dialysis. Am J Kidney Dis. 2018;27(6):478–86.
5. United States Renal Data System. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. 2022. https://adr.usrds.org/2022. Accessed 31 October 2022.